Our data showed that only ALDH1A1 plays a key role in ALDH-positive NSCLC stem cells, suggesting that ALDH1A1 could be a potential target in clinical treatment (Figure 6). This evidence concerns the gene LDHA and non-small cell lung carcinoma.